Consequently, loss of insulin/IGF-1 signaling in the brain, mediated by both the IR and the IGF1R, has generally been associated with an elevated risk of AD, cognitive decline, (premature) dementia, depression, and anxiety41–43. The gene discussed is IGF1; the disease is dementia.